147 related articles for article (PubMed ID: 23627635)
1. The effects of CD44 down-regulation on stem cell properties of head and neck cancer cell lines.
Kidwai F; Costea DE; Hutchison I; Mackenzie I
J Oral Pathol Med; 2013 Oct; 42(9):682-90. PubMed ID: 23627635
[TBL] [Abstract][Full Text] [Related]
2. C-Met pathway promotes self-renewal and tumorigenecity of head and neck squamous cell carcinoma stem-like cell.
Lim YC; Kang HJ; Moon JH
Oral Oncol; 2014 Jul; 50(7):633-9. PubMed ID: 24835851
[TBL] [Abstract][Full Text] [Related]
3. Stem cell profiling in head and neck cancer reveals an Oct-4 expressing subpopulation with properties of chemoresistance.
Reers S; Pfannerstill AC; Maushagen R; Pries R; Wollenberg B
Oral Oncol; 2014 Mar; 50(3):155-62. PubMed ID: 24387977
[TBL] [Abstract][Full Text] [Related]
4. SMURF1 silencing diminishes a CD44-high cancer stem cell-like population in head and neck squamous cell carcinoma.
Khammanivong A; Gopalakrishnan R; Dickerson EB
Mol Cancer; 2014 Dec; 13():260. PubMed ID: 25471937
[TBL] [Abstract][Full Text] [Related]
5. Potential stem cell marker CD44 is constitutively expressed in permanent cell lines of head and neck cancer.
Pries R; Witrkopf N; Trenkle T; Nitsch SM; Wollenberg B
In Vivo; 2008; 22(1):89-92. PubMed ID: 18396788
[TBL] [Abstract][Full Text] [Related]
6. Cellular characteristics of head and neck cancer stem cells in type IV collagen-coated adherent cultures.
Lim YC; Oh SY; Kim H
Exp Cell Res; 2012 Jun; 318(10):1104-11. PubMed ID: 22426199
[TBL] [Abstract][Full Text] [Related]
7. Frequency of cells expressing CD44, a head and neck cancer stem cell marker: correlation with tumor aggressiveness.
Joshua B; Kaplan MJ; Doweck I; Pai R; Weissman IL; Prince ME; Ailles LE
Head Neck; 2012 Jan; 34(1):42-9. PubMed ID: 21322081
[TBL] [Abstract][Full Text] [Related]
8. Wnt/β-catenin signalling maintains self-renewal and tumourigenicity of head and neck squamous cell carcinoma stem-like cells by activating Oct4.
Lee SH; Koo BS; Kim JM; Huang S; Rho YS; Bae WJ; Kang HJ; Kim YS; Moon JH; Lim YC
J Pathol; 2014 Sep; 234(1):99-107. PubMed ID: 24871033
[TBL] [Abstract][Full Text] [Related]
9. CD44 and SSEA-4 positive cells in an oral cancer cell line HSC-4 possess cancer stem-like cell characteristics.
Noto Z; Yoshida T; Okabe M; Koike C; Fathy M; Tsuno H; Tomihara K; Arai N; Noguchi M; Nikaido T
Oral Oncol; 2013 Aug; 49(8):787-95. PubMed ID: 23768762
[TBL] [Abstract][Full Text] [Related]
10. CD44(high) /ALDH1(high) head and neck squamous cell carcinoma cells exhibit mesenchymal characteristics and GSK3β-dependent cancer stem cell properties.
Seino S; Shigeishi H; Hashikata M; Higashikawa K; Tobiume K; Uetsuki R; Ishida Y; Sasaki K; Naruse T; Rahman MZ; Ono S; Simasue H; Ohta K; Sugiyama M; Takechi M
J Oral Pathol Med; 2016 Mar; 45(3):180-8. PubMed ID: 26399460
[TBL] [Abstract][Full Text] [Related]
11. Stem cell patterns in cell lines derived from head and neck squamous cell carcinoma.
Harper LJ; Piper K; Common J; Fortune F; Mackenzie IC
J Oral Pathol Med; 2007 Nov; 36(10):594-603. PubMed ID: 17944752
[TBL] [Abstract][Full Text] [Related]
12. A basal-cell-like compartment in head and neck squamous cell carcinomas represents the invasive front of the tumor and is expressing MMP-9.
Sterz CM; Kulle C; Dakic B; Makarova G; Böttcher MC; Bette M; Werner JA; Mandic R
Oral Oncol; 2010 Feb; 46(2):116-22. PubMed ID: 20036607
[TBL] [Abstract][Full Text] [Related]
13. Functional effects of SDF-1α on a CD44(+) CXCR4(+) squamous cell carcinoma cell line as a model for interactions in the cancer stem cell niche.
Faber A; Hoermann K; Stern-Straeter J; Schultz DJ; Goessler UR
Oncol Rep; 2013 Feb; 29(2):579-84. PubMed ID: 23232503
[TBL] [Abstract][Full Text] [Related]
14. CD44-negative cells in head and neck squamous carcinoma also have stem-cell like traits.
Oh SY; Kang HJ; Kim YS; Kim H; Lim YC
Eur J Cancer; 2013 Jan; 49(1):272-80. PubMed ID: 22770891
[TBL] [Abstract][Full Text] [Related]
15. Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells.
Bourguignon LYW; Earle C; Shiina M
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837080
[TBL] [Abstract][Full Text] [Related]
16. Cancer stem cells in head and neck squamous cell carcinoma.
Ailles L; Prince M
Methods Mol Biol; 2009; 568():175-93. PubMed ID: 19582427
[TBL] [Abstract][Full Text] [Related]
17. Apigenin inhibited hypoxia induced stem cell marker expression in a head and neck squamous cell carcinoma cell line.
Ketkaew Y; Osathanon T; Pavasant P; Sooampon S
Arch Oral Biol; 2017 Feb; 74():69-74. PubMed ID: 27886571
[TBL] [Abstract][Full Text] [Related]
18. Significance of site-specific prognosis of cancer stem cell marker CD44 in head and neck squamous-cell carcinoma.
Kokko LL; Hurme S; Maula SM; Alanen K; Grénman R; Kinnunen I; Ventelä S
Oral Oncol; 2011 Jun; 47(6):510-6. PubMed ID: 21514878
[TBL] [Abstract][Full Text] [Related]
19. Spatial distribution of cancer stem cells in head and neck squamous cell carcinomas.
Hildebrand LC; Carvalho AL; Lauxen IS; Nör JE; Cerski CT; Sant'Ana Filho M
J Oral Pathol Med; 2014 Aug; 43(7):499-506. PubMed ID: 24527751
[TBL] [Abstract][Full Text] [Related]
20. CD44+ cancer cell-induced metastasis: A feasible neck metastasis model.
Wu TF; Chen L; Bu LL; Gao J; Zhang WF; Jia J
Eur J Pharm Sci; 2017 Apr; 101():243-250. PubMed ID: 28215944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
